Acute Myelogenous Leukemia survival data

Description

Survival in patients with Acute Myelogenous Leukemia. The question at the time was whether the standard course of chemotherapy should be extended ('maintainance') for additional cycles.

Usage

aml
leukemia
Format

time:	survival or censoring time
status:	censoring status
x:	maintenance chemotherapy given? (factor)


%====================================================================================================================
library(survival)
leukemia.surv <- survfit(Surv(time, status) ~ x, data = aml) 
plot(leukemia.surv, lty = 2:3) 
legend(100, .9, c("Maintenance", "No Maintenance"), lty = 2:3) 
title("Kaplan-Meier Curves\nfor AML Maintenance Study") 
lsurv2 <- survfit(Surv(time, status) ~ x, aml, type='fleming') 
plot(lsurv2, lty=2:3, fun="cumhaz", 
xlab="Months", ylab="Cumulative Hazard") 
